Science 37 raises $31 mln
Science 37 said Oct. 18 that it raised $31 million in series B funding led by Redmile Group. Lux Capital and dRx Capital also participated, as well as Sanofi Genzyme BioVentures. Los Angeles-based Science 37 is a clinical research company.
18 October 2016•6 mins read
